Pharmaceuticals Businesses for Sale and Investment

Operates an online Ayurvedic and Unani healthcare ecosystem combining e-commerce, consultations, and diagnostics. - Functions as an aggregator platform listing 20–25 Ayurvedic and Unani brands, offering a wide range of traditional healthcare products. - Generates primary revenue through product sales. Revenue model - commission income from listed vendors. - Also acts as a stockist for select brands, enabling additional margins and inventory-driven sales. - Attracts over 30,000 monthly organic users through strong SEO presence in high-intent health and wellness categories. - Built on a scalable digital infrastructure including SEO-driven CMS with multiple page-one Google rankings. - Integrated platform features include doctor consultation services and a patient management system. - Offers diagnostics and blood test booking module, creating a comprehensive digital healthcare ecosystem. - Established for over seven years with a proven and profitable revenue model. - Registered as a private limited company with GST compliance, supporting structured operations and scalability. Company registered as a private limited company 5 years ago. - Positioned to scale further through product expansion, brand onboarding, and increased digital health service adoption.

Pharmaceutical API manufacturing company serving both pharmaceutical and cosmetic industries with specialized product offerings. - Produces APIs used in anti-depressants, anti-allergy, oncology, and pain management drugs, along with UV filters for skincare and sunscreen applications. - Operates in a niche segment with a focused client base of 5–6 active customers, ensuring repeat business and stable relationships. - Led by a promoter with over two decades of industry experience, bringing strong technical and regulatory expertise. - Fully compliant with industry standards, holding API test license, drug license, and environmental clearance. - Equipped with an 80,000-litre production capacity plant, currently running at 60–70% utilization, offering clear headroom for scale. - Workforce of 45 employees managing production, quality, and operations. - Revenue is driven by high-value B2B API manufacturing, where automated processes and bulk production enable strong output with a lean workforce. - Run rate sales have declined due to working capital constraints limiting production capacity and order fulfillment. - The company is not an USFDA approved company.

Operates a pharmaceutical manufacturing company producing a wide range of formulations for domestic and international markets. - Manufactures injectables (50% of revenue), tablets and capsules (30%), and liquids and ointments (20%). - Supplies products to hospitals, distributors, and pharmaceutical marketers across India and 40+ export markets. - Maintains a strong portfolio of over 1,400 registered products with an additional pipeline of approximately 1,300 products. - Generates around 40% of revenue from exports, reflecting established global market presence. - Equipped with certified manufacturing facilities compliant with WHO-GMP and ISO standards. - Backed by over two decades of operational experience in pharmaceutical manufacturing. - Operates scalable infrastructure with capacity for expansion and increased production. - Does not require USFDA approval for its current operations and target markets. - Registered with the Ministry of Corporate Affairs (MCA) and holds valid GST certification.

Developing a novel pharmaceutical drug targeting the treatment of chronic and episodic migraine conditions. - Designed to address neurological conditions, including trigeminal neuralgia, through specialized therapeutic intervention. - Intended for use in clinical settings under supervision of medical professionals. - Currently in pre-revenue stage with no commercial sales, as the product is awaiting clinical trial progression. - Registered under the FDA IND pathway, indicating initial regulatory alignment for clinical development. - Further regulatory approvals, such as successful completion of clinical trials and drug approval, will be required before commercialization. - Positioned as an early-stage drug development opportunity within the neurology and pain management segment. - Focused on addressing unmet medical needs in migraine and related neurological disorders.

Pharmaceutical marketing company focused on branded formulations, expanding presence in Delhi and northern India. - Markets a portfolio of products, including Cefixi O tab, Levista AM tab, Vista SP tab, FPM tab, Esom LS Cap, and Vista UP syrup. - Products cater to various therapeutic segments and are prescribed by doctors and healthcare providers. - Operates on an outsourced manufacturing model while selling under its own brand. - Serves 50–60 doctors and clinics, indicating an established prescriber network. - Generates revenue through product sales via medical representatives and direct distribution to clinics. - Led by a promoter with around 20 years of experience in the pharmaceutical industry. - Holds valid drug license, ensuring regulatory compliance. - Built a foundation for expansion with growing doctor network and regional market focus.

Operates a pharmaceutical distribution business supplying medicines and healthcare products across multiple channels. - Acts as an authorized distributor for over 80 pharmaceutical companies, including established domestic and multinational brands. - Distributes products to pharmacies, hospitals, and medical retailers, ensuring last-mile availability. - Follows a margin-based revenue model driven by product distribution volumes. - Maintains a diversified product portfolio across multiple healthcare categories. - Positioned as a supply chain intermediary with strong relationships across manufacturers and downstream customers. Since the business focuses solely on distribution, it doesn’t need a large workforce, logistics are handled by 3PL. - Registered with the Ministry of Corporate Affairs (MCA), ensuring regulatory compliance.

• Manufacturer and exporter of homeopathic OTC products, offering a wide portfolio including single remedy pills, dilutions, tablets, pellets, family kits, and blank sugar globules. • Operates as a digitally native, direct-to-consumer (D2C) brand with sales infrastructure built for its own website and major US marketplaces such as Amazon, eBay, and Walmart. • Holds a rare multinational structure with legal entities in the United States, India, and Canada, enabling global operations and regulatory alignment. • Manufacturing facility in India is US FDA registered and has undergone multiple inspections, with only minor observations in the latest review and clearance expected to resume exports. • Owns a US FDA Drug Master File (Type IV) for homeopathic blank pellets, positioning the business as a qualified global supplier of pharmaceutical-grade excipients. • Portfolio includes thousands of OTC SKUs listed with the US FDA, reflecting significant product depth and regulatory groundwork. • Brand is a registered trademark in the United States, strengthening intellectual property protection and market positioning. • Demonstrates strong customer validation through high ratings across major marketplaces and its own platform, indicating product acceptance despite pre-revenue status. • US-based fulfillment center is FDA-inspected with no observations, capable of handling large-scale order volumes and compliant with cGMP standards including recalls and complaint handling. • Backed by a founding team with decades of domain experience in homeopathy and established industry presence. • Built a scalable proprietary e-commerce infrastructure integrated with production systems and third-party platforms, ready to support high SKU and order volumes. • Currently pre-revenue with no sales recorded yet from the India facility; regulatory processes including US FDA inspection are in progress.

Operates a pharmaceutical marketing business focused on selling registered trademark products across India. - Markets products across general medicine, diabetic care, and proton pump inhibitor (PPI) segments. - Supplies to healthcare channels and end customers through an established distribution approach. - Maintains ready stock to support ongoing demand and timely order fulfillment. - Handles approximately 5–6 consignments per week, indicating active operations. - Fully compliant with required regulations, holding valid drug and food licenses.